Banco de Sabadell S.A bought a new position in McKesson Co. (NYSE:MCK) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 6,797 shares of the company’s stock, valued at approximately $1,059,000.
Other large investors have also recently bought and sold shares of the company. Synovus Financial Corp lifted its position in shares of McKesson by 62.8% in the third quarter. Synovus Financial Corp now owns 5,803 shares of the company’s stock worth $890,000 after buying an additional 2,238 shares in the last quarter. IFM Investors Pty Ltd purchased a new stake in shares of McKesson in the third quarter worth about $914,000. Legacy Capital Partners Inc. lifted its position in shares of McKesson by 11.5% in the fourth quarter. Legacy Capital Partners Inc. now owns 3,303 shares of the company’s stock worth $515,000 after buying an additional 340 shares in the last quarter. Cornerstone Wealth Management LLC purchased a new stake in shares of McKesson in the fourth quarter worth about $311,000. Finally, Rhumbline Advisers lifted its position in shares of McKesson by 1.3% in the fourth quarter. Rhumbline Advisers now owns 405,094 shares of the company’s stock worth $63,174,000 after buying an additional 5,389 shares in the last quarter. Institutional investors own 88.64% of the company’s stock.
A number of equities research analysts recently commented on the company. Barclays assumed coverage on McKesson in a research report on Thursday, March 8th. They issued an “equal weight” rating and a $165.00 target price on the stock. Bank of America began coverage on McKesson in a research report on Tuesday, February 27th. They set a “buy” rating and a $179.00 price objective on the stock. ValuEngine downgraded McKesson from a “buy” rating to a “hold” rating in a research report on Thursday, February 15th. Mizuho set a $186.00 price objective on McKesson and gave the company a “hold” rating in a research report on Wednesday, January 24th. Finally, Zacks Investment Research downgraded McKesson from a “buy” rating to a “hold” rating in a research report on Wednesday, February 21st. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and nine have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $176.74.
In other news, SVP Erin M. Lampert sold 1,413 shares of the company’s stock in a transaction that occurred on Thursday, March 1st. The stock was sold at an average price of $149.38, for a total transaction of $211,073.94. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.20% of the company’s stock.
McKesson Co. (NYSE:MCK) opened at $141.69 on Friday. The company has a market capitalization of $29,260.97, a P/E ratio of 6.28, a PEG ratio of 1.34 and a beta of 1.29. McKesson Co. has a 52 week low of $133.82 and a 52 week high of $178.86. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.61 and a current ratio of 1.07.
McKesson (NYSE:MCK) last released its earnings results on Thursday, February 1st. The company reported $3.41 EPS for the quarter, beating analysts’ consensus estimates of $2.92 by $0.49. The firm had revenue of $53.62 billion for the quarter, compared to analysts’ expectations of $51.98 billion. McKesson had a return on equity of 22.98% and a net margin of 2.34%. The company’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.04 earnings per share. sell-side analysts forecast that McKesson Co. will post 12.71 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, April 2nd. Stockholders of record on Thursday, March 1st will be paid a dividend of $0.34 per share. The ex-dividend date of this dividend is Wednesday, February 28th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.96%. McKesson’s dividend payout ratio is 6.03%.
TRADEMARK VIOLATION NOTICE: “Banco de Sabadell S.A Invests $1.06 Million in McKesson Co. (MCK)” was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://ledgergazette.com/2018/03/23/banco-de-sabadell-s-a-invests-1-06-million-in-mckesson-co-mck.html.
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.